Literature DB >> 25490795

Stroke: current concepts.

Megan Albertson, Jitendra Sharma.   

Abstract

Cerebrovascular accidents (CVAs) are the leading cause of disability and the fourth leading cause of death in the U.S. The WHO defines stroke as "rapidly developing clinical signs of focal disturbance of cerebral function lasting more than 24 hours with no apparent cause other than of vascular origin." Strokes are subdivided into two major classifications: ischemic (80-87 percent) andhemorrhagic (13-20 percent). Ischemic strokes occur from thrombi, emboli, or global hypoperfusion. Hemorrhagic strokes are either parenchymal (10 percent of all strokes) or subarachnoid (3 percent of all strokes). There are a variety of recognized risk factors for stroke which include: age, race, family history, hypertension, diabetes mellitus, atherosclerosis, cardiac arrhythmias, prosthetic valves, hyperlipidemia, cigarette smoking, and others (drugs or hormones). The initial assessment of a patient suspected of stroke should be done quickly enough to ensure maximal reperfusion of brain tissue. The steps to achieve this goal are: 1) exclude an intracranial hemorrhage, 2) assess for contraindications to thrombolytics, 3) characterize the infarct. The workup for a patient should first include a history (especially the time when neurologic symptoms began), a physical exam (including the NIHSS), and imaging studies (to rule out hemorrhagic components). In addition, several lab studies can also be obtained including: PT/INR, glucose, complete blood count, metabolic panel, creatine kinase, ECG, echocardiogram, lipid panel, carotid Doppler, MRA or CTA. Acute management of a stroke is primarily focused on stabilizing the patient and allowing as much reperfusion as possible for at-risk brain tissue. Stroke management in the acute setting includes: use of thrombolytics if indicated, and re-assessment to monitor progression. Several trials have been completed in pursuit of safety and effectiveness of intra-arterial stroke therapy for patients outside the recommended thrombolytic time window, but so far they are only experimental treatment options. The best preventative measures for first time or recurrent stroke are: starting or switching antiplatelet therapy, treatment of cardiovascular risk factors (atrial fibrillation and carotid stenosis), optimization of hypertension, dyslipidemia and diabetes mellitus management, and smoking cessation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25490795

Source DB:  PubMed          Journal:  S D Med        ISSN: 0038-3317


  9 in total

Review 1.  Association Between Cystatin C and the Risk of Ischemic Stroke: a Systematic Review and Meta-analysis.

Authors:  Yan Wang; Wei Li; Jun Yang; Mijuan Zhang; Chun'e Tian; Minjiang Ma; Qian Zhang
Journal:  J Mol Neurosci       Date:  2019-07-17       Impact factor: 3.444

2.  The incidence of cardiovascular thrombotic complications after laparoscopic resection in colorectal cancer in Japanese hospitals: A large-scale clinical study.

Authors:  Nobuki Ichikawa; Shigenori Homma; Tohru Funakoshi; Keisuke Obuchi; Takahiro Ohshima; Kazuhito Uemura; Hirofumi Kon; Yosuke Ohno; Ryoichi Yokota; Akinobu Taketomi
Journal:  Ann Gastroenterol Surg       Date:  2021-12-12

3.  Risk Factors, Clinical Features and Prognosis for Subtypes of Ischemic Stroke in a Chinese Population.

Authors:  Ya-Fu Tan; Li-Xuan Zhan; Xiao-Hui Chen; Jian-Jun Guo; Chao Qin; En Xu
Journal:  Curr Med Sci       Date:  2018-04-30

4.  Pipeline Flex embolisation device with Shield Technology for the treatment of patients with intracranial aneurysms: periprocedural and 6 month outcomes.

Authors:  James Yeomans; Lilian Sandu; Anand Sastry
Journal:  Neuroradiol J       Date:  2020-10-22

5.  Therapeutic Potential of Human Turbinate-Derived Mesenchymal Stem Cells in Experimental Acute Ischemic Stroke.

Authors:  Hyosun Lim; Sun Hwa Park; Sung Won Kim; Kyung-Ok Cho
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

6.  Physical activity to prevent stroke mortality in Brazil (1990-2019).

Authors:  Diego Augusto Santos Silva; Antonio Luiz Pinho Ribeiro; Fatima Marinho; Mohsen Naghavi; Deborah Carvalho Malta
Journal:  Rev Soc Bras Med Trop       Date:  2022-01-28       Impact factor: 2.141

Review 7.  Pyruvate dehydrogenase complex in cerebral ischemia-reperfusion injury.

Authors:  Alexa Thibodeau; Xiaokun Geng; Lauren E Previch; Yuchuan Ding
Journal:  Brain Circ       Date:  2016-07-13

Review 8.  Biomarkers for acute diagnosis and management of stroke in neurointensive care units.

Authors:  Olena Y Glushakova; Alexander V Glushakov; Emmy R Miller; Alex B Valadka; Ronald L Hayes
Journal:  Brain Circ       Date:  2016-03-11

9.  Twenty-four-hour blood pressure variability plays a detrimental role in the neurological outcome of hemorrhagic stroke.

Authors:  Huan-Xin Zhang; Qun-Xiong Fan; Shi-Zhen Xue; Min Zhang; Ji-Xian Zhao
Journal:  J Int Med Res       Date:  2018-06-04       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.